Celiac disease: Clinical manifestations, diagnosis and management
DOI:
https://doi.org/10.5281/zenodo.22134566Keywords:
celiac disease, gluten, gluten-free diet, transglutaminases, antibodies, primary health careAbstract
Introducción: La enfermedad celíaca es una enteropatía crónica de mecanismo inmunitario, precipitada por la ingestión de gluten en personas con predisposición genética (HLA-DQ2 o HLA-DQ8). Afecta aproximadamente al 1 % de la población mundial, con predominio femenino, y una proporción elevada de casos permanece sin diagnóstico. El objetivo fue sintetizar los aspectos clínicos, diagnósticos y terapéuticos de utilidad para la práctica clínica.
Materiales y métodos: Búsqueda no sistemática en PubMed de literatura publicada hasta 2023, con preferencia por guías de sociedades científicas, revisiones y estudios en revistas con revisión por pares.
Resultados: La presentación es heterogénea: formas digestivas, extraintestinales —anemia ferropénica, osteopenia, hipertransaminasemia, trastornos neurológicos o reproductivos— y subclínicas. El diagnóstico se apoya en serología específica (anti-transglutaminasa tisular IgA, con IgA total, y anti-endomisio) con el paciente consumiendo gluten, y en la biopsia duodenal (Marsh-Oberhuber); en pediatría seleccionada puede evitarse la biopsia. HLA-DQ2/DQ8 aporta sobre todo valor predictivo negativo. El único tratamiento es una dieta sin gluten estricta y de por vida, con educación, acompañamiento nutricional y seguimiento clínico y serológico.
Conclusiones: La adherencia insuficiente, la contaminación cruzada y el retraso diagnóstico son los principales obstáculos para un buen pronóstico, y sustentan programas estructurados de educación para pacientes y familias.
References
Ludvigsson JF, Leffler DA, Bai JC, Biagi F, Fasano A, Green PHR, et al. The Oslo definitions for coeliac disease and related terms. Gut. 2013;62(1):43-52. https://doi.org/10.1136/gutjnl-2011-301346
Catassi C, Verdu EF, Bai JC, Lionetti E. Coeliac disease. Lancet. 2022;399(10344):2413-26. https://doi.org/10.1016/S0140-6736(22)00794-2
Singh P, Arora A, Strand TA, Leffler DA, Catassi C, Green PH, et al. Global prevalence of celiac disease: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2018;16(6):823-836.e2. https://doi.org/10.1016/j.cgh.2017.06.037
Lebwohl B, Sanders DS, Green PHR. Coeliac disease. Lancet. 2018;391(10115):70-81. https://doi.org/10.1016/S0140-6736(17)31796-8
Caio G, Volta U, Sapone A, Leffler DA, De Giorgio R, Catassi C, et al. Celiac disease: a comprehensive current review. BMC Med. 2019;17(1):142. https://doi.org/10.1186/s12916-019-1380-z
Fuchs V, Kurppa K, Huhtala H, Mäki M, Kekkonen L, Kaukinen K. Delayed celiac disease diagnosis predisposes to reduced quality of life and incremental use of health care services and medicines: a prospective nationwide study. United European Gastroenterol J. 2018;6(4):567-75. https://doi.org/10.1177/2050640617751253
Lindfors K, Ciacci C, Kurppa K, Lundin KEA, Makharia GK, Mearin ML, et al. Coeliac disease. Nat Rev Dis Primers. 2019;5(1):3. https://doi.org/10.1038/s41572-018-0054-z
Rubio-Tapia A, Hill ID, Semrad C, Kelly CP, Greer KB, Limketkai BN, et al. American College of Gastroenterology guidelines update: diagnosis and management of celiac disease. Am J Gastroenterol. 2023;118(1):59-76. https://doi.org/10.14309/ajg.0000000000002075
Collin P, Salmi TT, Hervonen K, Kaukinen K, Reunala T. Dermatitis herpetiformis: a cutaneous manifestation of coeliac disease. Ann Med. 2017;49(1):23-31. https://doi.org/10.1080/07853890.2016.1222450
Leonard MM, Sapone A, Catassi C, Fasano A. Celiac disease and nonceliac gluten sensitivity: a review. JAMA. 2017;318(7):647-56. https://doi.org/10.1001/jama.2017.9730
Sapone A, Bai JC, Ciacci C, Dolinsek J, Green PHR, Hadjivassiliou M, et al. Spectrum of gluten-related disorders: consensus on new nomenclature and classification. BMC Med. 2012;10:13. https://doi.org/10.1186/1741-7015-10-13
Hadjivassiliou M, Grünewald RA, Sanders DS, Zis P, Croall I, Shanmugarajah PD, et al. The significance of low titre antigliadin antibodies in the diagnosis of gluten ataxia. Nutrients. 2018;10(10):1444. https://doi.org/10.3390/nu10101444
Husby S, Murray JA, Katzka DA. AGA clinical practice update on diagnosis and monitoring of celiac disease — changing utility of serology and histologic measures: expert review. Gastroenterology. 2019;156(4):885-9. https://doi.org/10.1053/j.gastro.2018.12.010
Husby S, Koletzko S, Korponay-Szabó I, Kurppa K, Mearin ML, Ribes-Koninckx C, et al. European Society Paediatric Gastroenterology, Hepatology and Nutrition guidelines for diagnosing coeliac disease 2020. J Pediatr Gastroenterol Nutr. 2020;70(1):141-56. https://doi.org/10.1097/MPG.0000000000002497
Al-Toma A, Volta U, Auricchio R, Castillejo G, Sanders DS, Cellier C, et al. European Society for the Study of Coeliac Disease (ESsCD) guideline for coeliac disease and other gluten-related disorders. United European Gastroenterol J. 2019;7(5):583-613. https://doi.org/10.1177/2050640619844125
Itzlinger A, Branchi F, Elli L, Schumann M. Gluten-free diet in celiac disease — forever and for all? Nutrients. 2018;10(11):1796. https://doi.org/10.3390/nu10111796
Aljada B, Zohni A, El-Matary W. The gluten-free diet for celiac disease and beyond. Nutrients. 2021;13(11):3993. https://doi.org/10.3390/nu13113993
Kreutz JM, Adriaanse MPM, van der Ploeg EMC, Vreugdenhil ACE. Narrative review: nutrient deficiencies in adults and children with treated and untreated celiac disease. Nutrients. 2020;12(2):500. https://doi.org/10.3390/nu12020500
Malamut G, Cellier C. Refractory celiac disease. Gastroenterol Clin North Am. 2019;48(1):137-44. https://doi.org/10.1016/j.gtc.2018.09.010
Kivelä L, Caminero A, Leffler DA, Pinto-Sanchez MI, Tye-Din JA, Lindfors K. Current and emerging therapies for coeliac disease. Nat Rev Gastroenterol Hepatol. 2021;18(3):181-95. https://doi.org/10.1038/s41575-020-00378-1
Downloads
Published
Issue
Section
License
Copyright (c) 2023 Isac de Paula Júnior, Thallys Bueno dos Santos, Ramón Mario Bellón Préstamo (Autor/a)

This work is licensed under a Creative Commons Attribution 4.0 International License.
Articles are distributed under the Creative Commons Attribution 4.0 International — CC BY 4.0 licence. Authors retain copyright and grant the journal the right of first publication. Any reuse must acknowledge authorship, cite the original source and indicate whether changes were made.


























